Últimos Artículos de Atherosclerosis
- arterial biomarkers in the evaluation, management and prognosis of aortic stenosis
- metabolic profiling links cardiovascular risk and vascular end organ damage
- cutaneous manifestations in familial hypercholesterolaemia
- clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: a post hoc analysis of the compass trial
- the 1st congress of the asian pacific society of atherosclerosis and vascular disease
- cd34 progenitors are predictive of mortality and are associated with physical activity in cardiovascular disease patients
- 69th meeting of the european atherosclerosis society
- the double action of hydrogen peroxide on the oxidative atherosclerosis battlefield
- extracellular vesicles in atherothrombosis and cardiovascular disease: friends and foes
- ticagrelor and the risk of infections during hospitalization in patients with st elevation myocardial infarction undergoing percutaneous coronary intervention
- journal article publishing support center
- myeloid associated lipin 1 transcriptional co regulatory activity is atheroprotective
- abdominal aorta plaques are better in predicting future cardiovascular events compared to carotid intima media thickness: a 20 year prospective study
- targeting the chemokine network in atherosclerosis
- editorial expression of concern: microrna 19b promotes macrophage cholesterol accumulation and aortic atherosclerosis by targeting atp binding cassette transporter a1 atherosclerosis volume 236, issue 1, september 2014, pages 215 226
- alirocumab treatment and neurocognitive function according to the cantab scale in patients at increased cardiovascular risk: a prospective, randomized, placebo controlled study
- 68th meeting of the european atherosclerosis society molecular cell biology and atherogenesis
- editorial expression of concern: microrna 27a b regulates cellular cholesterol efflux, influx and esterification hydrolysis in thp 1 macrophages
- smoking and sex differences in first manifestation of cardiovascular disease
- the emerging landscape of peptide based inhibitors of pcsk9